June 30th 2024, 2:00pm
By Jeff Levinson
"For their love, support and kindness, I am eternally grateful and blessed to have such people in our lives," said Levinson.
June 29th 2024, 6:00pm
By Haniza Zainal Abidin-Schlosser
After my mom died at 50 years old, I was certain I wasn't going to reach 50. I'm glad I was wrong.
June 29th 2024, 2:00pm
By Alex Biese
One specialist explained the ways palliative care, also known as supportive care, can assist patients during a breast cancer journey.
June 28th 2024, 7:00pm
By Brielle Benyon
At the CURE® Educated Patient® Breast Cancer Summit, an expert discussed integrative methods that can improve quality of life.
June 28th 2024, 5:00pm
By Felicia Mitchell
Losing my hair during chemo treatments wasn't the hard part. The process of it growing back was.
June 28th 2024, 3:00pm
By Ashley Chan
From Judge Frank Caprio opening up about his diagnosis of pancreatic cancer and treatment to an “Ink Master” star dying from testicular cancer, here’s what’s going on in the oncology space this week.
June 28th 2024, 1:37pm
The Food and Drug Administration approved Tepylute — a liquid form of thiotepa — for the treatment of patients with breast or ovarian cancer.
June 28th 2024, 1:00pm
By Jezebel Corpuz
Having an unwavering cancer community on Facebook has given me strength, which all started after they sent a teal blanket to me.
June 27th 2024, 9:00pm
By HEATHER VALENZUELA, B.S.N., RN
For 41 years, Fiona Wilkie, RN, has been making oncology patients (and her co- workers) smile.
June 27th 2024, 7:00pm
Patients can discuss minimally invasive robotic liver cancer surgery with their care teams. The process tends to be safe and effective, an expert said.
June 27th 2024, 5:00pm
By Carla Deschamps
During my recovery period after colon cancer, I focused on visualizing myself living a healthy life and healing after cancer treatment.
June 27th 2024, 3:00pm
Patients with HR-positive metastatic breast cancer can expect to undergo biomarker testing both at diagnosis and again if the disease progresses.
June 27th 2024, 1:00pm
By Debbie Denardi
From experiencing the death of loved ones to receiving my own diagnosis and becoming involved in advocacy, my cancer experience has come full circle.
June 27th 2024, 12:09am
The Food and Drug Administration approved Epkinly, a bispecific T-cell engager, for certain patients with follicular lymphoma.
June 26th 2024, 9:00pm
Patients saw improved event-free survival and overall survival with presurgical Imfinzi and chemotherapy followed by surgery and postsurgical Imfinzi.
Standing Up to Cancer is Far More Than Slogans
Perioperative Immunotherapy ‘Is The Revolution’ in NSCLC
FDA Accepts New Drug Application for Relacorilant in Ovarian Cancer
How Does Cancer Treatments Affect Menopause and Fertility?